Avadel stock rises 8% as FDA grants tentative approval to its Jazz's sleep disorder drug rival [Seeking Alpha]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Seeking Alpha
Avadel stock rises 8% as FDA grants tentative approval to its Jazz's sleep disorder drug rivalJul. 19, 2022 8:58 AM ETAvadel Pharmaceuticals plc (AVDL)JAZZBy:RavikashSA News Editor2 CommentsGrandbrothersThe U.S. Food and Drug Administration (FDA)grantedNASDAQ:The company said the final approval for Lumryz, also known as FT218, is pendingdisposition of a U.S. patent, No. 8,731,963 (the 'REMS patent').The patent in question was granted to Jazz Pharmaceuticals' (REMS (Risk Evaluation and Mitigation Strategy)according to the FDAThe '963 patent allegedly covered using a computer-implemented system which addressed certain FDA-required REMS conditions of using Xyrem as per the label, according to areportAvadel said in a July 19 press release that it has filed a motion in the U.S. District Court for the District of Delaware on June 23, to delist the REMS patent from FDAâ??s Orange Book.The company added that the tentative approval suggests that Lumryz met all required quality, safety, and eff
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024PR Newswire
- Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024PR Newswire
JAZZ
Earnings
- 2/28/24 - Beat
JAZZ
Sec Filings
- 4/9/24 - Form 4
- 3/8/24 - Form 4
- 3/7/24 - Form 4
- JAZZ's page on the SEC website